# A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects

> **NCT05277350** · PHASE1 · COMPLETED · sponsor: **SNIPR Biome Aps.** · enrollment: 36 (actual)

## Conditions studied

- E.Coli Infections
- Bloodstream Infection

## Interventions

- **DRUG:** SNIPR001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05277350
- **Lead sponsor:** SNIPR Biome Aps.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-24
- **Primary completion:** 2022-11-30
- **Final completion:** 2023-05-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05277350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05277350, "A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05277350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*